Revenue vs Net income
Reported dollars from 10-Q / 10-K filings. Q4 bars are derived (annual less nine months) where the 10-K does not tag Q4 separately.
Margin trend
Gross, operating and net margin. Margins are derived from reported dollars.
Revenue YoY growth
Year-over-year change vs the same quarter (or fiscal year) a year earlier. Shown where the prior-year period is in the 8-quarter snapshot (latest four quarters).
Income statement
From 10-Q / 10-K XBRL. Values in reported dollars; EPS in $/share; share counts in shares.
| FY23 | FY24 | FY25 | |
|---|---|---|---|
| Revenue | $195.3B | $247.1B | $274.9B |
| YoY | — | +26.6% | +11.2% |
| Cost of goods sold | $133.8B | $182.5B | $215.0B |
| YoY | — | +36.4% | +17.8% |
| Gross profit | — | — | — |
| YoY | — | — | — |
| Research & development | — | — | — |
| YoY | — | — | — |
| Selling, general & administrative | $14.8B | $14.8B | $14.6B |
| YoY | — | +0.1% | -1.5% |
| Operating income | $8.5B | $9.4B | $9.2B |
| YoY | — | +10.3% | -2.3% |
| Pretax income | $5.5B | $5.3B | $7.8B |
| YoY | — | -4.4% | +47.7% |
| Income tax | $141.0M | $1.5B | $1.5B |
| YoY | — | +957.4% | +0.1% |
| Net income | — | — | — |
| YoY | — | — | — |
| EPS — basic | $17.57 | $12.25 | $22.33 |
| YoY | — | -30.3% | +82.3% |
| EPS — diluted | $17.39 | $12.12 | $22.18 |
| YoY | — | -30.3% | +83.0% |
| Weighted shares — basic | — | — | — |
| Weighted shares — diluted | 296.9M | 283.2M | 268.6M |
Balance sheet
Point-in-time values at each quarter (or fiscal year) end.
| FY23 | FY24 | FY25 | |
|---|---|---|---|
| Cash & equivalents | $7.8B | $7.5B | $7.7B |
| YoY | — | -3.5% | +1.7% |
| Marketable securities (current) | — | — | — |
| YoY | — | — | — |
| Accounts receivable | $17.7B | $24.2B | $28.8B |
| YoY | — | +36.7% | +18.7% |
| Inventory | $5.6B | $6.7B | $7.3B |
| YoY | — | +18.5% | +9.7% |
| Total current assets | $37.4B | $48.9B | $47.8B |
| YoY | — | +30.8% | -2.2% |
| Total assets | $152.8B | $155.9B | $157.9B |
| YoY | — | +2.0% | +1.3% |
| Total current liabilities | $48.7B | $58.0B | $56.3B |
| YoY | — | +19.0% | -2.8% |
| Total liabilities | $106.4B | $114.6B | $116.0B |
| YoY | — | +7.7% | +1.2% |
| Total equity | $46.2B | $41.0B | $41.7B |
| YoY | — | -11.2% | +1.7% |
| Shares outstanding | 292.5M | 273.8M | 263.5M |
| YoY | — | -6.4% | -3.8% |
Cash flow
Quarterly values derived from year-to-date filings (Q4 from the 10-K). Free cash flow = operating cash flow − capital expenditures.
| FY23 | FY24 | FY25 | |
|---|---|---|---|
| Operating cash flow | $11.8B | $10.4B | $9.6B |
| YoY | — | -12.3% | -7.4% |
| Capital expenditures | — | — | — |
| YoY | — | — | — |
| Free cash flow | — | — | — |
| YoY | — | — | — |
| Dividends paid | — | — | — |
| YoY | — | — | — |
| Share repurchases | $2.3B | $7.0B | $3.6B |
| YoY | — | +208.0% | -48.5% |
Margins & ratios
Derived from the reported dollars above — no separate source.
| FY23 | FY24 | FY25 | |
|---|---|---|---|
| Gross margin | — | — | — |
| Operating margin | 4.4% | 3.8% | 3.3% |
| Net margin | — | — | — |
| Free cash flow margin | — | — | — |
| Effective tax rate | 2.6% | 28.3% | 19.2% |
| Current ratio | 0.77x | 0.84x | 0.85x |
| Total liabilities / equity | 2.30x | 2.79x | 2.78x |
Peer comparison — latest full year
Same sector (Health Care), sorted by revenue. All figures from the same EDGAR XBRL snapshot.
| Ticker | Revenue | Revenue YoY | Gross margin | Operating margin | Net margin | FCF margin |
|---|---|---|---|---|---|---|
| CI FY25 · this stock | $274.9B | +11.2% | — | 3.3% | — | — |
| UNH FY25 | $447.6B | +11.8% | — | 4.2% | 2.7% | 3.6% |
| CVS FY25 | $402.1B | +7.8% | — | 1.2% | 0.4% | 1.9% |
| ELV FY25 | $199.1B | +12.5% | — | 3.6% | 2.8% | 1.6% |
| JNJ FY25 | $94.2B | +6.0% | 67.9% | — | 28.5% | 20.9% |
| LLY FY25 | $65.2B | +44.7% | — | — | 31.7% | — |
| MRK FY25 | $65.0B | +1.3% | — | — | 28.1% | 19.0% |
| ABBV FY25 | $61.2B | +8.6% | — | 24.6% | 6.9% | 29.1% |
| BMY FY25 | $48.2B | -0.2% | — | — | 14.6% | 26.7% |
| TMO FY25 | $44.6B | +3.9% | — | 17.4% | 15.0% | 14.1% |
| ABT FY25 | $44.3B | +5.7% | — | 18.2% | 14.7% | 16.7% |
Source: SEC EDGAR XBRL company facts (10-Q / 10-K), snapshot generated 2026-11-03 for 218 tickers. Q4 values are derived as the 10-K annual less the first nine months, since Q4 is not separately tagged in company facts; cash-flow quarterly values are derived from year-to-date filings the same way. Free cash flow = operating cash flow − capital expenditures. Blank cells mean the filing does not report that line item under a standard US-GAAP tag — nothing is estimated or filled in. Descriptive research, not investment advice. How EarnIQ builds fundamentals.